Posts tagged first-in-man
Following up 8 years after two ‘first-in-man’ knee osteoarthritis treatments

In October 2017, Professor James Richardson delivered a momentous announcement at the 11th annual Oswestry Cartilage Symposium. After more than 20 years of trials and research, the National Institute for Health and Care Excellence (NICE) finally approved chondrocyte cell therapy for the treatment of articular cartilage defects. This historic decision is anticipated to have a profound impact on the cartilage repair field in the UK and globally.

Read More